Navigation Links
Best Cyclotron Systems/Best Theratronics and MIT/INFN, a Part of the DAEdALUS Collaboration, are Developing a Range of Low to High Power, Next Generation Cyclotrons
Date:6/17/2013

Vancouver, British Columbia, Canada (PRWEB) June 17, 2013

BCSI and BTL have invested in a Multi Million USD test and research facility, the only one of its kind in the world, for these scientists to design, develop and test prototype concepts for these Cyclotrons. This research will help BCSI and BTL to introduce a new generation of modern low to high power Cyclotrons next year. Currently, BCSI and BTL are expecting nearly 50 Million USD worth of orders for new Cyclotrons, in addition to the 20 Million USD worth of orders for 70 MeV and 15 MeV Cyclotrons, to be shipped this year. These are the result of BTL and BCSI investing more than 20 Million USD in product, research, design, development and manufacturing of these unique modern Cyclotrons, using the latest in technological advancements.

BCSI and BTL are hosts to a Massachusetts Institute of Technology (MIT)/Italian National Laboratory of Legnaro (INFN) experimental group, part of the DAEdALUS Collaboration (http://www2.lns.mit.edu/~conrad/daedalus.html) aimed at world-class neutrino experiments using a new generation of high-current cyclotrons. The DAEdALUS Group has installed and is currently testing its new ion source, developed at the Catania INFN laboratory, at the TeamBest Vancouver test and research facility. Professor Janet Conrad of the MIT Department of Physics reported that, “…It is nice to see basic science and applications of physics move forward hand-in-hand so productively.”

The key feature of the high current accelerator is the use of singly-ionized molecules of hydrogen (H2+), that are subsequently converted to two protons (2H+), and delivered to high-power neutrino-production targets.

The BCSI and BTL test and research facility has assembled a new well-instrumented Cyclotron Central Region Test Stand. This comprehensive research facility produces, transports and injects particles into a flexibly designed test cyclotron, capable of accelerating ions up to a maximum of 1 MeV. This low energy allows ion source and injection dynamics to be studied together with the first few turns of the actual cyclotron, without generating any radioactivity. Consequently, the MIT/INFN teams can test their developments and designs at an early stage before finalizing the details of their much larger accelerators.

The test stands are used to confirm and validate Ion Source and Injection Systems for all the TeamBest Cyclotrons, such as the B15, B25, B35 and the B70. The BCSI and BTL new test stand is arguably the smallest cyclotron in the world today, and with it and the DAEdALUS group, TeamBest is contributing to one of the largest cyclotron design teams in the world. The test stand experiments optimize the accelerator characteristics before final products are manufactured and delivered to customers. This will reduce commissioning time at the customer site and installation will be executed as planned.

BTL’s president, Krishnan Suthanthiran, has said, “There is so much synergy between our research and development and our science friends! We are pleased that they are at our test and research facility in Vancouver.“ The BCSI Director of Operations and Research, Dr. Richard Johnson reports that, “The ideas that DAEdALUS has brought to our laboratory will surely be applied to our health care equipment development.”

About Best Theratronics
Best Theratronics (BTL) was founded more than 60 years ago with their invention of the first commercial Gamma Beam Teletherapy (GBT) machine for treating cancer and non-malignant tumors with radiation. Canada issued a special stamp to commemorate this breakthrough invention. BTL has been manufacturing and supplying these machines that are considered the gold standard and work horses of radiation oncology departments globally since its invention and commercialization. In addition, BTL manufactures a range of Blood Irradiators, Cyclotrons and other products. For more information, please visit http://www.theratronics.com.

About Best Medical International
Best Medical International (BMI) has served the medical community with the highest quality products and unparalleled customer service for more than 35 years. BMI, headquartered in Springfield, VA, USA encompasses a family of medical companies known as TeamBest, with a proven track record of innovation, quality and service. TeamBest provides solutions for External Beam Radiation Therapy and Brachytherapy including: Best® Iodine-125 and Palladium-103 seeds; Brachytherapy accessories, Radiotherapy and diagnostic imaging devices, Gold fiducial markers, MOSFET patient dosimetry, patient immobilization, cardiovascular brachytherapy and medical physics/QA instrumentation, repair and calibration.

http://www.bestcyclotron.com
http://www.theratronics.com
http://www.teambest.com

CONTACT:

Krishnan Suthanthiran
Founder & President of TeamBest Companies
krish@teambest.com

Richard Johnson
Director of Cyclotron Research Operations
richard.johnson(at)teambest(dot)com
(604)657-6694

Read the full story at http://www.prweb.com/releases/2013/6/prweb10836541.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
2. Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor
3. IU Simon Cancer Center joins WellPoint in developing health care solutions
4. Surprising results for use of dialysis for kidney failure in developing world
5. Pediatric tumors traced to stem cells in developing brain​​
6. Researchers developing new multiple sclerosis drug that can be taken orally
7. Researchers developing bioadhesive gel to protect women from HIV and HSV infections
8. Undergrads invent cell phone screener to combat anemia in developing world
9. LA BioMed investigator, Dr. Yutaka Niihara, developing novel cellular therapy
10. Global sleeplessness epidemic affects an estimated 150 million in developing world
11. By studying animal health, researchers find improved ways for developing, testing cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
(Date:10/12/2017)... GRAND RAPIDS, Mich. (PRWEB) , ... October 12, ... ... OnSite Wellness, has been named one of Michigan’s 2017 Best and Brightest in ... Best and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... COPENHAGEN, Denmark , Oct. 2, 2017 The ... tool in the struggle to reverse the tide of prescription ... plan for regulating their medicine intake and stepping down their ... is set to launch in December 2017; the first 100,000 ... access. Learn more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology: